Control your world well with Human Primates models

    PharmaLegacy Laboratories (Shanghai) Co., Ltd is a professional supplier which provides a variety of Non-Human Primates models, to provide customers withIndustry leadingNon-Human Primates models ,Respiratory Disease Modelx2a3868enand Non-Human Primates models and so on. Since the company had been established in Building 7, 388 Jialilue Road Zhangjiang High-Tech Park Pudong District Shanghai,Pudongxin District,City area,Shanghai,China, adhere to people-oriented ,and the quality of survival, to the credibility of development,our company have made an outstanding achievement.

   The advantage of PharmaLegacyCDX Modelis that it can provide more professional and thoughtful solutions timely and accurately according to the actual needs of customers.At the same time, Our company follow the latest developments on Business services,Medical service,Medical insurance, and establish long and steady partnership relation with many well-known enterprises in the same industry , to provide customers with the most professional, advanced Respiratory Disease Model.Details:Non-human primates model (NHP) have closer phylogenetic relationship to human and the disease targets in NHP models share high cross-reactivity to the human target specific biological molecules which do not react with rodent counterpart. PharmaLegacy has therefore developed and validated serials of NHP platforms, covering Inflammation/ Autoimmune Diseases, Bone/Orthopedics, Respiratory Disease, as well as Pharmacokinetics Profiling Assay to test pharmacological effects and mechanisms of candidate drugs especially for therapeutic monoclonal antibodies. Experiments involving non-human primates (NHPs) include toxicity testing for medical and non-medical substances; studies of infectious disease, such as HIV and hepatitis; neurological studies; behavior and cognition; reproduction; genetics; and xenotransplantation. Around 65,000 NHPs are used every year in the United States, and around 7,000 across the European Union. Most of the NHPs used are one of three species of macaques, accounting for 79% of all primates used in research in the UK, and 63% of all federally funded research grants for projects using primates in the U.S. Lesser numbers of marmosets, tamarins, spider monkeys, owl monkeys, vervet monkeys, squirrel monkeys, and baboons are used in the UK and the US. Great Apes have not been used in the UK since a Government policy ban in 1998.

   PharmaLegacy always adheres to the corporate purpose: Sincere service, the pursuit of perfectionand advancing with the times,make progress together with51-100 people people, and go hand in hand to get innovation and a win-win situation. To get more information about Non-Human Primates models,, you can log in and look through PharmaLegacy official website:www.pharmalegacy.com